Medicare Enrolled

Dr. Davinder Sekhon, M.D.

Urology Physician · Pensacola, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4724 NORTH DAVIS HWY, Pensacola, FL 32503
8506964000
In practice since 2006 (19 years)
NPI: 1053334318 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sekhon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sekhon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sekhon

Dr. Davinder Sekhon is an urology physician in Pensacola, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sekhon performed 25,264 Medicare services across 3,222 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sekhon received a total of $7,598 from 43 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sekhon is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in FL $7,598 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 95815 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
25,264
Medicare services
Top 5% in FL for urology physician
3,222
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,330 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection 14,580 $0 $1
Contrast dye for imaging (iodine-based) 4,275 $0 $3
Identification of organisms by genetic analysis, amplified probe technique 1,596 $34 $156
Office visit, established patient (30-39 min) 921 $89 $224
Office visit, established patient (20-29 min) 465 $60 $148
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique 402 $69 $364
Yeast/candida DNA test 268 $34 $123
Infectious disease DNA/RNA test 268 $34 $161
Injection, gadobenate dimeglumine (multihance), per ml 200 $1 $16
Injection, triptorelin pamoate, 3.75 mg 183 $295 $2,196
X-ray of abdomen, 1 view 152 $19 $84
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique 134 $34 $149
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique 134 $34 $149
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique 134 $34 $123
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique 134 $34 $123
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique 133 $34 $177
Piflufolastat f-18, diagnostic, 1 millicurie 117 $474 $1,380
Automated urinalysis 108 $2 $16
Bladder ultrasound after voiding 90 $8 $94
Complete ultrasound scan behind abdominal cavity 85 $76 $361
Diagnostic exam of bladder and urethra using an endoscope 84 $174 $664
Initial hospital admission, moderate complexity 80 $105 $297
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 77 $26 $141
Drug injection, under skin or into muscle 73 $11 $93
Hospital follow-up visit, moderate complexity 63 $64 $157
Blood creatinine level 51 $5 $30
New patient office visit (45-59 min) 51 $111 $343
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant 46 $41 $2,932
Ultrasound scan of pelvic region through rectum 46 $26 $418
Insertion of stent in ureter using an endoscope 29 $112 $1,986
Simple change of bladder tube 27 $77 $367
Ct scan of abdomen and pelvis before and after contrast 26 $277 $1,776
Urinalysis with microscopic exam 26 $3 $27
Biopsy of prostate gland 24 $103 $730
Ct scan of abdomen and pelvis without contrast 24 $143 $892
Simple insertion of temporary bladder tube 23 $47 $249
Office visit, established patient, complex (40-54 min) 20 $136 $301
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope 16 $254 $639
Nuclear medicine studies of kidney, blood flow, and function 16 $268 $1,058
Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries 16 $359 $4,924
Injection, furosemide, up to 20 mg 16 $0 $7
Mri scan of pelvis before and after contrast 14 $269 $3,458
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant 13 $169 $3,774
Nuclear medicine study from skull base to mid-thigh with ct scan 13 $1,213 $4,120
Shock wave crushing of kidney stones 11 $449 $3,538
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
78.1% medium
21.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,598
Total received (2018-2024)
Avg $1,085/year across 7 years
Top 27% in FL for urology physician
43
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,199 (81.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,399 (18.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$839
2023
$991
2022
$1,236
2021
$1,313
2020
$659
2019
$1,457
2018
$1,105

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,866
NeoTract Inc.
$595
Janssen Biotech, Inc.
$534
PFIZER INC.
$444
Sumitomo Pharma America, Inc.
$413
ABBVIE INC.
$413
Teleflex LLC
$290
Allergan Inc.
$250
PROCEPT BioRobotics Corporation
$234
AbbVie Inc.
$197
Janssen Scientific Affairs, LLC
$195
Coloplast Corp
$190
COLOPLAST CORP
$158
Allergan, Inc.
$150
180 Medical, Inc.
$144
Myovant Sciences Inc.
$144
Medtronic USA, Inc.
$136
Dendreon Pharmaceuticals LLC
$117
Medtronic, Inc.
$111
UROVANT SCIENCES INC
$107
Augmenix, Inc.
$100
Ferring Pharmaceuticals Inc.
$89
UroGen Pharma, Inc.
$80
Boston Scientific Corporation
$66
AbbVie, Inc.
$65
Endo Pharmaceuticals Inc.
$54
Amgen Inc.
$53
Tolmar, Inc.
$45
Bayer Healthcare Pharmaceuticals Inc.
$45
Merck Sharp & Dohme LLC
$43
PROGENICS PHARMACEUTICALS, INC.
$33
AstraZeneca Pharmaceuticals LP
$32
Verity Pharmaceuticals Inc.
$31
ROCHESTER MEDICAL CORPORATION
$23
Clarus Therapeutics Inc.
$21
Tempus AI, Inc
$21
Progenics Pharmaceuticals, Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Genentech USA, Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$15
Mission Pharmacal Company
$15
Avadel Specialty Pharmaceuticals, LLC
$12
Antares Pharma, Inc.
$12
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVYCAZ · Androgel · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENTLECATH · GentleCath · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lumenis Pulse 120H · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · NURO · Noctiva · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Prolia · REZUM · SPEEDICATH · SpaceOAR · SpeediCath · TOVIAZ · Tecentriq · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $30 per 100 Medicare services performed
Looking for an urology physician in Pensacola?
Compare urology physicians in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
19
Per 100K population
5.9
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sekhon is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sekhon experienced with testosterone injection?
Based on Medicare claims data, Dr. Sekhon performed 14,580 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sekhon receive payments from pharmaceutical companies?
Yes. Dr. Sekhon received a total of $7,598 from 43 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sekhon's costs compare to other urology physicians in Pensacola?
Dr. Sekhon's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sekhon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →